![]() |
Home
Version française
Corporate
Contact Webmaster
|
|
|
|
Free search :
|
Application to the encapsulation and controlled release of active compounds - Protein loaded PLGA microspheres - Protein loaded CaCO3 microspheres - Impregnated CaCO3 microspheres Anaplerotic Krebs cycle stimulators as therapeutic targets - Metabolic action - Blood-Brain Barrier permeant A promising cancer vaccine candidate - Adjuvant therapy in association with standard strategie - Cancer relapse prevention - No immunotolerance problem - Different sort of molecules may be included in the film - Small molecules of PM<5000Da and even PM<1000 Da keep their activity - Activity is stable up to 50 layers depth - Multifonctionalized bioactive materials - Tuned activity of the molecules - New properties due to the mixture of polycations and polyanions Better patient classification for high-risk of relapse than TMN histological - A novel approach for the analysis of the intra-tumoral immune infiltrate - Better predictive value than the gold-standard histologic classification - Stratification of patients at high risk of relapse - THYX: dTMP route synthesis of mostly pathogenic bacteria - Mutual exclusion of Thyx and thya in the genome of bacteria and viruses - The human genome does not bear theThyx gene - TLR5 agonist - No significant systemic pro-inflammatory effects - EPCR receptor responsible for thrombosis - Differenciation of 3 haplotypes for the EPCR gene - Diagnostic kit for thrombotic risks Theranostic kit for chemotherapy - Vascular Endothelial Cadherin, a body fluids protein - Detection in plasma or serum - Brain solid tumors (glioblastoma) but currently investigating other cancers - An infinite variety of architectures - A long term use of this film due to the important stability - Neither allergic reaction nor excessive inflammatory response - siRNA proof of concept in vivo - drugable membrane protein High Throughput screening software for multiple targets - Tracing over 1000 simulataneous targets - In heterogeneous media with high noise - Dynamic tracing as well (instantanous) Prognosis of survival in solid cancer and AML - Linked to angiogenesis - Poor and bad prognosis of event-free and overall survival - Extremely sensitive detection of isoform IL15 and sIL15Ra implicated in the response to treatment in Crohn's disease - Inflammatory disease and Biomarker in Crohn's disease - Response to Infliximab in Crohn's disease - A specific modulation of IL15 and sIL15Ra - Application #1: cell models for research and screening - Application #2: cell-based biotherapies - In-vitro method based on inactivation of MafB and c-Maf genes in monocytes - Gene therapy for the SCID: severe combined immunodeficiency. - Radiosensible SCID observed in this study. - Identification of the implication of a gene in SCID. - NPHS2: identified and mapped to chromosom 1 - A hot spot of mutation - Prediction of reccurence after transplant 1st truly established skin substitutes worldwide - Application in screening and toxicology - Provide all possible phenotypes - Skin lines with reproductible results - EFGR antagonist or inhibitor of EFGR for treatment - CD9 implied in the EGFR activation - Enlargement of treatment to other alloimune diseases - The first useful biomarker for multiple sclerosis diagnostic - Identification of a group receptive to IFN-β treatment - Reduction of the public health costs Use as a labeling marker/tool for research, in-vitro diagnostic - Consistent and permanent fluorescence - Replicable and industrial process, classical surface chemistry - Can bind to any biologicals (DNA, RNA, protein, etc) Early diagnosis-differentiate at stage 0 between calcification and tumor - Diagnostic imaging of breast cancer. Relapse prognosis. - Alternative to MRI-based mammography (false positive and higher cost) - Radiotherapy and therapeutic application The concept : sublimation under vaccum followed by solid deposition - Sublimation followed by deposition alters compound conformation - Compound conformation of the deposit gains in therapeutic efficacy - Gain in efficacy reflects gain in bioavailability or biological activity A new therapeutic window through immunoregulation - Diagnosis + Therapeutic proof of concept on the target - Minimal peptidic sequence identified - Significant clinical evidence - Product: CNF1 bacterial toxin as adjuvant - Application: mucosal vaccination, proof of concept in nasal and oral models - Novel action mechanism: transient and reversible activation of Rho-GTPases CNV-based biomarker in sporadic pancreatic cancer - Diagnostic of a predisposition to the pancreatic cancer - Inhibitor of the genes proteins activities for the treatment - Identification of a CNV signature. - HSP70: a new therapeutic target - Smaller inhibitors for an easier use - Peptidic aptameres as therapeutic agents Novel original target from dormant tuberculosis bacillus (TB) - Product: carbapenems - Target: L,D-transpeptidase, expressed in dormant tuberculosis bacillus (TB) - Indication: latent tuberculosis - Biomarker of breast and ovaries cancers: PTPL1 - Development of an immunocytochemistry dosage - Diagnostic and prognostic tests - Fibrosis diagnosis - Lysil Oxidase Enzyme binders as imaging agents - Acute treatment should be provided - Molecular signatures of osseous and lung metastasis - Experiments on human samples - Targeted therapy - STIM1: a protein that activates NFAT - NFAT induces cells proliferation and cardiac hypertrophy - RNA interference to inhibit STIM1 Control of the IL-15 affinity for its receptor IL-15α - Interleukin-15 induces NK and T cell proliferation and activation - Development of new IL-15 mutants - Prevention and treatment of human pathology by IL-15 activity modulation - Prediction of survival in HNSCC patients - Increase level of soluble IL-15Rα in HNSCC patients - soluble α chain: biomarker of these cancers - Non-invasive pulse wave velocity measurement - High fidelity pressure microsensor - Vascular alteration prognostic Inflammation and Biomarker in Rheumatoid Arthritis (RA) - Polymorphisms of the TNF gene : identification of a single TNF haplotype - A single TNF haplotype influences the response of Adalimumab in RA - Large pharmacogenetic study - HCC is an heterogeneous group of tumours - A reliable classification for adapted treatments - 6 distinct subgroups from genotype-phenotype correlation - Diagnosis devoid from risk - Free hemoglobin as biomarker - Studies on both morbid and non-morbid obesity Imaging, In vitro diagnostic, radiotherapy and immunotherapy - Protein Receptor expressed in vascular cells for prognosis - Expressed in prostate tumors and other solid cancers - Imaging application, Development of tumor blood test - Molecular classification - Marker genes for thyroid disease diagnosis - Precise identification of all thyroid diseases Prognosis of disease outcome for treatment selection - More acurate patient stratification than current ISS standard - Especially for high risk patients - Blood sample - Chemical-based amplification of the pathological prion protein - Applicable to human and animal samples - Product #1: HB-19 and related compounds, specific ligands of nucleolin - Product #2: EF-Tu of F. Tularensis as a vaccine - Novel targets: EF-Tu / cell surface nucleolin interaction Radiopharmaceuticals with simplified preparation - Binds specifically to hepatocytes - Safe and cost efficient (based on human albumin) - Scintigraphic agent (technetium) - Optimized fusion protein for efficient antigen processing - Specific monoclonal antibody targeting dendritic cells - Product: vaccine (preventive and therapeutic) - Novel therapeutic vaccination method - Novel action mechanism: CCL3 dépendant - Product: inhibitors of HCV replication Based on a protein and its corresponding receptor - Diagnostic imaging of non small cell lung (potentially colon, breast) cance - Monitoring of cancer Severity and its progression - In-vitro diagnostic and radiotherapy - Chemical familly already in clinical development - Specific inhibition of the bcl2 family - Chemical Therapy orally available
|
|
|||||
|
|
|||||||
|
LEGAL INFORMATION INSERM TRANSFERT © copyright 2008 |
|||||||